Illumina (ILMN) Competitors $99.25 -0.80 (-0.80%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$99.15 -0.10 (-0.10%) As of 07/11/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, CRL, BIO, BRKR, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Its Competitors Agilent Technologies Mettler-Toledo International Waters Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies (NYSE:A) and Illumina (NASDAQ:ILMN) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment. Does the media refer more to A or ILMN? In the previous week, Illumina had 16 more articles in the media than Agilent Technologies. MarketBeat recorded 34 mentions for Illumina and 18 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 0.99 beat Illumina's score of 0.61 indicating that Agilent Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 11 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 12 Very Positive mention(s) 5 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of A or ILMN? 87.4% of Agilent Technologies shares are owned by institutional investors. Comparatively, 89.4% of Illumina shares are owned by institutional investors. 0.3% of Agilent Technologies shares are owned by insiders. Comparatively, 2.6% of Illumina shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is A or ILMN more profitable? Agilent Technologies has a net margin of 17.59% compared to Illumina's net margin of -22.25%. Agilent Technologies' return on equity of 25.92% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Agilent Technologies17.59% 25.92% 13.24% Illumina -22.25%25.54%8.62% Do analysts prefer A or ILMN? Agilent Technologies currently has a consensus target price of $139.77, suggesting a potential upside of 13.31%. Illumina has a consensus target price of $125.11, suggesting a potential upside of 26.05%. Given Illumina's higher probable upside, analysts clearly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilent Technologies 0 Sell rating(s) 6 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.54Illumina 2 Sell rating(s) 9 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.40 Which has higher earnings and valuation, A or ILMN? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgilent Technologies$6.63B5.29$1.29B$4.0530.46Illumina$4.34B3.62-$1.22B-$6.07-16.35 Which has more risk & volatility, A or ILMN? Agilent Technologies has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500. Comparatively, Illumina has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. SummaryAgilent Technologies beats Illumina on 10 of the 17 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.71B$2.94B$5.56B$9.09BDividend YieldN/A2.41%5.25%4.02%P/E Ratio-16.3520.8528.2620.26Price / Sales3.62266.92409.50152.11Price / Cash21.1642.1137.1257.67Price / Book6.637.638.045.49Net Income-$1.22B-$55.05M$3.19B$250.45M7 Day Performance-1.18%8.43%3.62%4.79%1 Month Performance14.17%8.14%5.98%9.59%1 Year Performance-14.51%1.62%29.39%16.41% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.8649 of 5 stars$99.25-0.8%$125.11+26.1%-14.5%$15.71B$4.34B-16.359,030Trending NewsAnalyst ForecastAAgilent Technologies4.8612 of 5 stars$119.21-1.8%$140.92+18.2%-6.7%$33.86B$6.51B29.4317,900Analyst ForecastMTDMettler-Toledo International4.1369 of 5 stars$1,188.28-1.7%$1,300.36+9.4%-10.0%$24.69B$3.87B29.6317,300Positive NewsAnalyst ForecastWATWaters4.3494 of 5 stars$346.35-1.1%$388.00+12.0%+16.7%$20.61B$2.96B31.437,600Trending NewsAnalyst ForecastTECHBio-Techne4.8874 of 5 stars$51.54-3.0%$72.00+39.7%-30.0%$8.08B$1.16B62.853,100News CoverageAnalyst ForecastCRLCharles River Laboratories International4.5579 of 5 stars$153.93-2.0%$171.85+11.6%-26.1%$7.56B$4.05B-236.8220,100Positive NewsAnalyst UpgradeBIOBio-Rad Laboratories4.6466 of 5 stars$247.45-1.6%$324.25+31.0%-15.5%$6.73B$2.57B-3.257,700News CoveragePositive NewsAnalyst DowngradeAnalyst RevisionBRKRBruker4.8807 of 5 stars$41.27-2.8%$52.89+28.2%-32.4%$6.25B$3.37B79.3711,396Positive NewsHigh Trading VolumePACBPacific Biosciences of California1.8378 of 5 stars$1.47-8.1%$2.06+40.2%-12.5%$441.13M$152.36M-0.53730News CoveragePositive NewsGap DownHBIOHarvard Bioscience4.2556 of 5 stars$0.44-2.2%$3.00+577.2%-86.4%$19.59M$94.14M-0.34490Trending NewsTMOThermo Fisher Scientific4.9925 of 5 stars$418.76-2.5%$604.05+44.2%-20.6%$158.08B$42.88B24.56125,000Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
